![Peter Lamb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Peter Lamb occupies the position of Chief Scientific Officer & EVP-Scientific Strategy at Exelixis, Inc. Dr. Lamb previously was Director-Transcription Research at Ligand Pharmaceuticals, Inc. He received a doctorate from the University of London and an undergraduate degree from the University of Cambridge.
Former positions of Peter Lamb
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | 15/12/2022 |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/09/2000 |
Training of Peter Lamb
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Peter Lamb
